Matches in Wikidata for { <http://www.wikidata.org/entity/Q90043739> ?p ?o ?g. }
- Q90043739 description "2020 nî lūn-bûn" @default.
- Q90043739 description "2020年の論文" @default.
- Q90043739 description "2020年学术文章" @default.
- Q90043739 description "2020年学术文章" @default.
- Q90043739 description "2020年学术文章" @default.
- Q90043739 description "2020年学术文章" @default.
- Q90043739 description "2020年学术文章" @default.
- Q90043739 description "2020年学术文章" @default.
- Q90043739 description "2020年學術文章" @default.
- Q90043739 description "2020年學術文章" @default.
- Q90043739 description "2020年學術文章" @default.
- Q90043739 description "2020年學術文章" @default.
- Q90043739 description "2020年學術文章" @default.
- Q90043739 description "2020년 논문" @default.
- Q90043739 description "article científic" @default.
- Q90043739 description "article scientific" @default.
- Q90043739 description "article scientifique" @default.
- Q90043739 description "articol științific" @default.
- Q90043739 description "articolo scientifico" @default.
- Q90043739 description "artigo científico" @default.
- Q90043739 description "artigo científico" @default.
- Q90043739 description "artigo científico" @default.
- Q90043739 description "artikel ilmiah" @default.
- Q90043739 description "artikull shkencor" @default.
- Q90043739 description "artikulong pang-agham" @default.
- Q90043739 description "artykuł naukowy" @default.
- Q90043739 description "artículo científico publicado en 2020" @default.
- Q90043739 description "artículu científicu" @default.
- Q90043739 description "bilimsel makale" @default.
- Q90043739 description "bài báo khoa học" @default.
- Q90043739 description "naučni članak" @default.
- Q90043739 description "scienca artikolo" @default.
- Q90043739 description "scientific article published on 04 March 2020" @default.
- Q90043739 description "scientific article published on 4 March 2020" @default.
- Q90043739 description "scientific article published on 4 March 2020" @default.
- Q90043739 description "teaduslik artikkel" @default.
- Q90043739 description "tieteellinen artikkeli" @default.
- Q90043739 description "tudományos cikk" @default.
- Q90043739 description "vedecký článok" @default.
- Q90043739 description "vetenskaplig artikel" @default.
- Q90043739 description "videnskabelig artikel udgivet 4. marts 2020" @default.
- Q90043739 description "vitenskapelig artikkel" @default.
- Q90043739 description "vitskapeleg artikkel" @default.
- Q90043739 description "vědecký článek" @default.
- Q90043739 description "wetenschappelijk artikel" @default.
- Q90043739 description "wissenschaftlicher Artikel" @default.
- Q90043739 description "επιστημονικό άρθρο" @default.
- Q90043739 description "мақолаи илмӣ" @default.
- Q90043739 description "наукова стаття, опублікована в березні 2020" @default.
- Q90043739 description "научна статия" @default.
- Q90043739 description "научная статья" @default.
- Q90043739 description "научни чланак" @default.
- Q90043739 description "научни чланак" @default.
- Q90043739 description "מאמר מדעי" @default.
- Q90043739 description "مقالة علمية نشرت في 4 مارس 2020" @default.
- Q90043739 description "৪ মার্চ ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q90043739 description "บทความทางวิทยาศาสตร์" @default.
- Q90043739 description "სამეცნიერო სტატია" @default.
- Q90043739 name "Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression" @default.
- Q90043739 name "Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression" @default.
- Q90043739 type Item @default.
- Q90043739 label "Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression" @default.
- Q90043739 label "Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression" @default.
- Q90043739 prefLabel "Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression" @default.
- Q90043739 prefLabel "Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression" @default.
- Q90043739 P1433 Q90043739-1AC5C3CF-6355-438B-A296-D703044B5D6C @default.
- Q90043739 P1476 Q90043739-F23CFAF4-DB43-44DF-9DE6-9D8813234109 @default.
- Q90043739 P2093 Q90043739-4AC67DD2-09C7-4A04-9001-EF7F03F5AE0A @default.
- Q90043739 P2093 Q90043739-6A438A97-2028-4888-9022-02F5320B6D39 @default.
- Q90043739 P2093 Q90043739-6BD71726-10FB-468F-9A48-FCB17697DF90 @default.
- Q90043739 P2093 Q90043739-75DCB6F9-8AA6-4D16-8F27-6D32436603EE @default.
- Q90043739 P2093 Q90043739-8FB9DEE6-C346-4538-A671-EB5F8336D269 @default.
- Q90043739 P2093 Q90043739-908E227F-76E4-4350-B751-CE0D26667903 @default.
- Q90043739 P2093 Q90043739-A84DFE67-227B-492A-96E1-D6C76148C591 @default.
- Q90043739 P2093 Q90043739-D010EED0-7565-4826-B51A-C2B0C6636CDA @default.
- Q90043739 P2093 Q90043739-E2713CE7-792A-4DC2-916A-B38C8AA55B30 @default.
- Q90043739 P2093 Q90043739-E435B200-D115-4EB1-AAA6-67DD7D82A981 @default.
- Q90043739 P2093 Q90043739-F59669B4-87FE-46A5-8B5A-F70ECB924743 @default.
- Q90043739 P2093 Q90043739-F7292F05-908A-421B-8D65-9098D9CA6665 @default.
- Q90043739 P31 Q90043739-02291E53-C67E-4D8F-9BD2-E0A0FC045C50 @default.
- Q90043739 P356 Q90043739-F897116B-F346-4F09-B45C-552C7A17F52E @default.
- Q90043739 P50 Q90043739-34007A97-7203-4580-A26A-79AA06F5A139 @default.
- Q90043739 P50 Q90043739-3FF06B10-C6F5-4E65-B0D8-333EF4B5B114 @default.
- Q90043739 P50 Q90043739-62356713-AAB6-4DF2-883E-6101B23FB406 @default.
- Q90043739 P577 Q90043739-D3E0BB7B-E5B4-47F5-8D60-6A3A02F17986 @default.
- Q90043739 P698 Q90043739-675F1D4C-C435-46C7-B5F5-74273A98052E @default.
- Q90043739 P921 Q90043739-0B1D71E2-6A30-4BAA-B041-B86B9C6B69E1 @default.
- Q90043739 P921 Q90043739-7CCB9347-7F35-45F8-8FD4-84F9FCDE8851 @default.
- Q90043739 P356 BJH.16474 @default.
- Q90043739 P698 32130737 @default.
- Q90043739 P1433 Q4970200 @default.
- Q90043739 P1476 "Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression" @default.
- Q90043739 P2093 "Ascensión López-Díaz de Cerio" @default.
- Q90043739 P2093 "Carlos Grande" @default.
- Q90043739 P2093 "Esther Pena" @default.
- Q90043739 P2093 "Eva Bandrés" @default.
- Q90043739 P2093 "Jesús Feliu" @default.
- Q90043739 P2093 "Jorge M Núñez-Córdoba" @default.
- Q90043739 P2093 "Marcio Andrade-Campos" @default.
- Q90043739 P2093 "María T Olave" @default.